MICHAEL TURNER: Open Payments
NPI 1598851404 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 49 payments from 16 companies in 2025. Trend: 2023 $423 · 2024 $973 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $198 |
| Organon LLC | 10 | $191 |
| Janssen Biotech, Inc. | 7 | $144 |
| Novartis Pharmaceuticals Corporation | 3 | $90 |
| LEO Pharma Inc. | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| UCB, Inc. | 3 | $59 |
| GENZYME CORPORATION | 2 | $47 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| PFIZER INC. | 2 | $30 |
Products named: VTAMA, TREMFYA, RINVOQ, DUPIXENT, SKYRIZI, COSENTYX, Bimzelx, ADBRY.
Industry payments across CO — which companies pay providers there.
